Target Price | $66.38 |
Price | $53.54 |
Potential |
23.98%
register free of charge
|
Number of Estimates | 21 |
21 Analysts have issued a price target Sanofi Sponsored ADR 2026 .
The average Sanofi Sponsored ADR target price is $66.38.
This is
23.98%
register free of charge
$72.79
35.96%
register free of charge
$56.87
6.21%
register free of charge
|
|
A rating was issued by 25 analysts: 20 Analysts recommend Sanofi Sponsored ADR to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sanofi Sponsored ADR stock has an average upside potential 2026 of
23.98%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 44.44 | 51.25 |
8.69% | 15.32% | |
EBITDA Margin | 31.98% | 30.66% |
1.42% | 4.12% | |
Net Margin | 13.54% | 18.80% |
5.23% | 38.84% |
19 Analysts have issued a sales forecast Sanofi Sponsored ADR 2025 . The average Sanofi Sponsored ADR sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Sanofi Sponsored ADR EBITDA forecast 2025. The average Sanofi Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Sanofi Sponsored ADR Analysts have issued a net profit forecast 2025. The average Sanofi Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 2.40 | 3.84 |
3.00% | 60.00% | |
P/E | 13.93 | |
EV/Sales | 2.77 |
10 Analysts have issued a Sanofi Sponsored ADR forecast for earnings per share. The average Sanofi Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
Sanofi Sponsored ADR...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
TD COWEN |
Locked
➜
Locked
|
Locked | Apr 06 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Mar 30 2025 |
HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Apr 07 2025 |
Locked
TD COWEN:
Locked
➜
Locked
|
Apr 06 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Mar 30 2025 |
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Mar 19 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Mar 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.